The Australian startup inoculates crops with symbiotic microbial fungi that boost plants’ natural ability to sequester carbon in the soil they grow in.
It’ll use the Series A capital to hire talent and build an in-house facility to create larger quantities of its ingredients for food manufacturers.
It’s using soybeans to produce casein, the protein found in cows’ milk which gives cheese its characteristic “melt, stretch, and mouthfeel.”
The Ginkgo Bioworks spinout will use the proceeds from the BlackRock and Ontario Teachers’-led Series B round for R&D, commercialization, and hiring.
Quantum hardware’s depth of analysis would likely advance our understanding of the genetic code of plants – and humans – far beyond what we know today.
Fund VII takes Flagship’s total assets under management to $14.1 billion.
With origins in the beauty and wellness space, Geltor is entering the food and beverage industy with its first vegan collagen ingredient.
“We’re looking forward to combining [Ginkgo’s] genome editing and fermentation capabilities with our chemical technologies and industry insights in health and crop sciences,” said Sumitomo Chemical CTO Hiroshi Ueda.
AquaBounty has encountered a number of challenges in its mission to commercialize its GE salmon including a labeling disclosure controversy.
Biometric tech has become part of our everyday lives, whether we’re opening a bank account, crossing a border, or unlocking a phone – and it’s coming to our food, too.
The US Congress has issued a report on dangerous levels of heavy metals in baby food. But these substances can’t simply be regulated away, a molecular biologist writes.
Pairwise is also working on blackberries without seeds and cherries without pits in pursuit of its aim to get more Americans snacking on fruits and veggies.
Dyadic and TurtleTree will collaborate on growing recombinant proteins that can be used as alt-protein growth factors, affordably and at industrial scale.
The North Carolina startup is tapping into the microbiome to develop non-antibiotic treatments for respiratory infections in cattle and other animals.
The Israeli startup is using a combination of AI and bio-engineering to develop functional ingredients and therapeutics for people with gluten and peanut allergies.
The Swiss biotech startup offers a rapid test that provides ISO-certified results in minutes and is “as simple as making an espresso” for its customers.
It’s one of the first agrifoodtech exits of 2021.
Purissima intends to fundamentally change the production and consumption of bioactive ingredients that can help us to live longer, healthier lives.
The Israeli bio-herbicide startup will use the funding for product development, scaling its operations, and regulatory advancements.
John Legend and Natalie Portman have backed the San Francisco startup, which also announced a new plant that will increase production of its mycelium-based leather alternative by 10x.
